241 related articles for article (PubMed ID: 36944292)
21. Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii.
Gopikrishnan M; George Priya Doss C
Microb Pathog; 2023 Apr; 177():106049. PubMed ID: 36858184
[TBL] [Abstract][Full Text] [Related]
22. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
23. Unveiling MurE ligase potential inhibitors for treating multi-drug resistant
Altharawi A; Alqahatani SM; Alanazi MM; Tahir Ul Qamar M
J Biomol Struct Dyn; 2024 Mar; 42(5):2358-2368. PubMed ID: 37099644
[No Abstract] [Full Text] [Related]
24. Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii.
Amera GM; Khan RJ; Pathak A; Jha RK; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2020 Nov; 100():107675. PubMed ID: 32731183
[TBL] [Abstract][Full Text] [Related]
25. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
26. Structure prediction and discovery of inhibitors against phosphopantothenoyl cysteine synthetase of
Gupta A; Vijayan V; Pant P; Kaur P; Singh TP; Sharma P; Sharma S
J Biomol Struct Dyn; 2022; 40(21):11405-11417. PubMed ID: 34348086
[No Abstract] [Full Text] [Related]
27. Carbapenem resistance gene crisis in A. baumannii: a computational analysis.
Zahra N; Zeshan B; Ishaq M
BMC Microbiol; 2022 Dec; 22(1):290. PubMed ID: 36463105
[TBL] [Abstract][Full Text] [Related]
28. Homology modeling and molecular dynamic simulation of UDP-N-acetylmuramoyl-l-alanine-d-glutamate ligase (MurD) from Mycobacterium tuberculosis H37Rv using in silico approach.
Isa MA
Comput Biol Chem; 2019 Feb; 78():116-126. PubMed ID: 30504089
[TBL] [Abstract][Full Text] [Related]
29. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
30. Structure Based in Silico Screening Revealed a Potent Acinetobacter Baumannii Ftsz Inhibitor From Asinex Antibacterial Library.
Navid A; Ahmad S; Sajjad R; Raza S; Azam SS
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3008-3018. PubMed ID: 34375286
[TBL] [Abstract][Full Text] [Related]
31. Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against
Gopal D; Muddebihalkar AG; Skariyachan S; C AU; Kaveramma P; Praveen U; Shankar RR; Venkatesan T; Niranjan V
J Biomol Struct Dyn; 2020 Sep; 38(15):4584-4599. PubMed ID: 31625462
[No Abstract] [Full Text] [Related]
32. Discovery of the Lead Molecules Targeting the First Step of the Histidine Biosynthesis Pathway of
Ahmad N; Singh A; Gupta A; Pant P; Singh TP; Sharma S; Sharma P
J Chem Inf Model; 2022 Apr; 62(7):1744-1759. PubMed ID: 35333517
[No Abstract] [Full Text] [Related]
33. BRCA1/TP53 tumor proteins inhibited by novel analogues of curcumin - Insight from computational modelling, dynamic simulation and experimental validation.
Aloor LJ; Skariyachan S; Raghavamenon AC; Kumar KM; Narayanappa R; Uttarkar A; Niranjan V; Cherian T
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126989. PubMed ID: 37739292
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
35. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
[TBL] [Abstract][Full Text] [Related]
36. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
37. Identification of inhibitor binding hotspots in Acinetobacter baumannii β-ketoacyl acyl carrier protein synthase III using molecular dynamics simulation.
Ha Y; Jang M; Lee S; Lee JY; Lee WC; Bae S; Kang J; Han M; Kim Y
J Mol Graph Model; 2020 Nov; 100():107669. PubMed ID: 32659632
[TBL] [Abstract][Full Text] [Related]
38. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
Ahmad S; Ranaghan KE; Azam SS
Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
Ibrahim MAA; Abdelrahman AHM; Hassan AMA
Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
[TBL] [Abstract][Full Text] [Related]
40. Screening of potential phytomolecules against MurG as drug target in nosocomial pathogen
Lokhande KB; Pawar SV; Madkaiker S; Shrivastava A; Venkateswara SK; Nawani N; Wani M; Ghosh P; Singh A
J Biomol Struct Dyn; 2024; 42(1):495-508. PubMed ID: 36974974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
